Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis.

Juvenile or type 2 hemochromatosis (JH) is transmitted as a recessive trait that leads to severe iron overload and organ damage typically before age 30 years. Linkage to a locus on chromosome 1q has been found in most patients with JH. The recently identified causal gene encodes hemojuvelin, a protein with a proposed crucial role in iron metabolism. A second, rare type of JH, with clinical expression identical to the 1q-linked form, is due to inactivation of hepcidin, the key regulator of iron homeostasis. Here we report the spectrum of mutations of the hemojuvelin gene (HJV) in 34 patients who did not show hepcidin mutations. This represents the largest cohort of patients with JH collected worldwide. We identified 17 different (16 novel) mutations of HJV, both at the homozygous and at the compound heterozygous state. Mutations either generate premature termination codons or were missense substitutions, affecting highly conserved residues, relevant to the protein structure and/or function.

[1]  L. Rubbia‐Brandt,et al.  Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene. , 2004, Blood.

[2]  N. Andrews,et al.  Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice. , 2004, Blood.

[3]  C. Férec,et al.  HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. , 2004, Blood.

[4]  M. Cazzola,et al.  Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). , 2004, Blood.

[5]  Marie-Pierre Dubé,et al.  Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.

[6]  G. Ruggeri,et al.  Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. , 2003, Clinical chemistry.

[7]  R. Chapman,et al.  Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. , 2003, Human molecular genetics.

[8]  P. Gasparini,et al.  Juvenile hemochromatosis locus maps to chromosome 1q in a French Canadian population , 2003, European Journal of Human Genetics.

[9]  Tomas Ganz,et al.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. , 2003, Blood.

[10]  P. Bruneval,et al.  Cardiogenic shock in a young woman revealing juvenile haemochromatosis , 2003, Heart.

[11]  W. Stremmel,et al.  Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. , 2003, Blood.

[12]  P. Brissot.  The discovery of the new haemochromatosis gene , 2003 .

[13]  E. Beutler.  The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. , 2003, Blood.

[14]  M. Hentze,et al.  Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis , 2003, Nature Genetics.

[15]  J. Kushner,et al.  Clinical consequences of iron overload in hemochromatosis homozygotes. , 2003, Blood.

[16]  D. Purdie,et al.  Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis , 2003, The Lancet.

[17]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[18]  A. Bomford.  Genetics of haemochromatosis , 2002, The Lancet.

[19]  W. Sly,et al.  Decreased liver hepcidin expression in the Hfe knockout mouse. , 2002, Blood cells, molecules & diseases.

[20]  M. Cazzola,et al.  Natural history of juvenile haemochromatosis , 2002, British journal of haematology.

[21]  C. Beaumont,et al.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Sly,et al.  Pathogenesis of hereditary hemochromatosis: genetics and beyond. , 2002, Seminars in gastrointestinal disease.

[23]  J. Koziol,et al.  Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA , 2002, The Lancet.

[24]  M. De Gobbi,et al.  Juvenile hemochromatosis. , 2002, Seminars in hematology.

[25]  C. Beaumont,et al.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Loukopoulos,et al.  Linkage to chromosome 1q in Greek families with juvenile hemochromatosis. , 2001, Blood cells, molecules & diseases.

[27]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[28]  Exclusion of ZIRTL as candidate gene of juvenile hemochromatosis and refinement of the critical interval on 1q21. , 2000, Blood cells, molecules & diseases.

[29]  Paolo Gasparini,et al.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.

[30]  C. Férec,et al.  Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, canada). , 2000, Blood cells, molecules & diseases.

[31]  J. Olynyk,et al.  A population-based study of the clinical expression of the hemochromatosis gene. , 1999, The New England journal of medicine.

[32]  M. Cazzola,et al.  Juvenile hemochromatosis locus maps to chromosome 1q. , 1999, American journal of human genetics.

[33]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.